AR

NCT01721577 — Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Status: TERMINATED · clinicaltrials.gov

NCT00365222 — Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT02669173 — Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT05053880 — A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

Status: UNKNOWN · clinicaltrials.gov

NCT00782756 — Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

Status: COMPLETED · clinicaltrials.gov

NCT03660761 — Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

Status: COMPLETED · clinicaltrials.gov

NCT01808820 — Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT00979862 — Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT00761280 — Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT02864368 — Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens

Status: TERMINATED · clinicaltrials.gov

NCT01700569 — Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT00293423 — GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Status: COMPLETED · clinicaltrials.gov

NCT05775458 — Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Status: RECRUITING · clinicaltrials.gov

NCT05686798 — Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Status: RECRUITING · clinicaltrials.gov

NCT05768087 — Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients

Status: RECRUITING · clinicaltrials.gov

NCT00813943 — Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

Status: COMPLETED · clinicaltrials.gov

NCT05756985 — Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Status: RECRUITING · clinicaltrials.gov

NCT07389278 — Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT02223052 — Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Status: COMPLETED · clinicaltrials.gov

NCT06831526 — Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT03332355 — Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2

Status: TERMINATED · clinicaltrials.gov

NCT04051606 — Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT01582269 — A Study in Recurrent Glioblastoma (GB)

Status: COMPLETED · clinicaltrials.gov

NCT05333588 — The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

Status: UNKNOWN · clinicaltrials.gov

NCT05909618 — Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

Status: RECRUITING · clinicaltrials.gov

NCT02502708 — Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

Status: COMPLETED · clinicaltrials.gov

NCT02177578 — Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT04743310 — Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Status: COMPLETED · clinicaltrials.gov

NCT04209790 — Neoadjuvant Chemoradiation for Resectable Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT00797940 — Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)

Status: WITHDRAWN · clinicaltrials.gov

NCT01124240 — Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene

Status: UNKNOWN · clinicaltrials.gov

NCT00068510 — Vaccine Therapy in Treating Patients With Malignant Glioma

Status: COMPLETED · clinicaltrials.gov

NCT02968940 — Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT03034135 — Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT03477513 — Personalized Radiation Therapy for GBM

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT06059690 — Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Status: RECRUITING · clinicaltrials.gov

NCT03115333 — DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT07552233 — NK Cell Therapy for Malignant Solid Brain Tumors

Status: RECRUITING · clinicaltrials.gov

NCT01631552 — Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Status: COMPLETED · clinicaltrials.gov

NCT00387933 — Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma

Status: COMPLETED · clinicaltrials.gov

NCT00253487 — Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas

Status: COMPLETED · clinicaltrials.gov

NCT04444427 — Evaluation of GLR2007 for Advanced Solid Tumors

Status: COMPLETED · clinicaltrials.gov

NCT04772846 — Chloroquine for Glioblastoma.

Status: UNKNOWN · clinicaltrials.gov

NCT01849146 — Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT02698280 — Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma

Status: COMPLETED · clinicaltrials.gov

NCT00104091 — Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Status: COMPLETED · clinicaltrials.gov

NCT00704080 — A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

Status: COMPLETED · clinicaltrials.gov

NCT01790503 — A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT04657146 — Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma

Status: SUSPENDED · clinicaltrials.gov

NCT03251027 — Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT07413796 — Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Status: RECRUITING · clinicaltrials.gov

NCT03107780 — Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Status: TERMINATED · clinicaltrials.gov

NCT05399524 — Functional and Ultrasound Guided Resection of Glioblastoma

Status: UNKNOWN · clinicaltrials.gov

NCT04180046 — Utility of Primary Glioblastoma Cell Lines

Status: UNKNOWN · clinicaltrials.gov

NCT03626896 — Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Status: COMPLETED · clinicaltrials.gov

NCT03033524 — Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT00376103 — Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Status: TERMINATED · clinicaltrials.gov

NCT00433381 — Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Status: COMPLETED · clinicaltrials.gov

NCT02433392 — Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.

Status: TERMINATED · clinicaltrials.gov

NCT00590681 — Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT00255671 — Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Status: COMPLETED · clinicaltrials.gov

NCT02366728 — DC Migration Study for Newly-Diagnosed GBM

Status: COMPLETED · clinicaltrials.gov

NCT00624728 — Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)

Status: COMPLETED · clinicaltrials.gov

NCT06672575 — A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT00071539 — Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Status: COMPLETED · clinicaltrials.gov

NCT01011231 — Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Status: TERMINATED · clinicaltrials.gov

NCT03705351 — Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Status: TERMINATED · clinicaltrials.gov

NCT01499251 — Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT00584883 — A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT02977780 — INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Status: RECRUITING · clinicaltrials.gov

NCT02104882 — INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study

Status: COMPLETED · clinicaltrials.gov

NCT02685605 — Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT01985256 — Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Status: COMPLETED · clinicaltrials.gov

NCT01607905 — Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Status: COMPLETED · clinicaltrials.gov

NCT06072586 — A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Status: RECRUITING · clinicaltrials.gov

NCT05653622 — Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT02179086 — Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT00509431 — Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Status: COMPLETED · clinicaltrials.gov

NCT04671459 — TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine

Status: UNKNOWN · clinicaltrials.gov

NCT06665724 — Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Status: COMPLETED · clinicaltrials.gov

NCT01865162 — Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study

Status: COMPLETED · clinicaltrials.gov

NCT02661282 — Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT02311920 — Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Status: COMPLETED · clinicaltrials.gov

NCT07365280 — Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT03176160 — LITT Palliative Treatment for Patients With Malignant Gliomas

Status: WITHDRAWN · clinicaltrials.gov

NCT02465268 — Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT01925573 — Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)

Status: TERMINATED · clinicaltrials.gov

NCT03596086 — HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Status: RECRUITING · clinicaltrials.gov

NCT00006246 — Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Status: COMPLETED · clinicaltrials.gov

NCT05106296 — Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Status: RECRUITING · clinicaltrials.gov

NCT00039494 — Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors

Status: COMPLETED · clinicaltrials.gov

NCT00979173 — Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma

Status: COMPLETED · clinicaltrials.gov

NCT02800486 — Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Status: RECRUITING · clinicaltrials.gov

NCT01317888 — Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

Status: UNKNOWN · clinicaltrials.gov

NCT04221503 — Niraparib/TTFields in GBM

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT01702792 — Derivation of Tumor Specific Hybridomas

Status: TERMINATED · clinicaltrials.gov

NCT03463265 — Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT00727506 — BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma

Status: COMPLETED · clinicaltrials.gov

NCT05956821 — Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Status: RECRUITING · clinicaltrials.gov

NCT06346821 — Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data

Status: COMPLETED · clinicaltrials.gov

NCT02394665 — Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT00345163 — A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)

Status: COMPLETED · clinicaltrials.gov

NCT01062399 — Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT00003567 — Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Status: TERMINATED · clinicaltrials.gov

NCT04547621 — HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Status: UNKNOWN · clinicaltrials.gov

NCT00516607 — Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

Status: UNKNOWN · clinicaltrials.gov

NCT07138001 — Phase 2 Clinical Trial of KH617

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT06492486 — Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT03603379 — Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas

Status: COMPLETED · clinicaltrials.gov

NCT00752323 — Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma

Status: COMPLETED · clinicaltrials.gov

NCT06160596 — Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis

Status: RECRUITING · clinicaltrials.gov

NCT02815410 — Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

Status: UNKNOWN · clinicaltrials.gov

NCT04863950 — Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT04600817 — A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)

Status: UNKNOWN · clinicaltrials.gov

NCT01478854 — Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide

Status: COMPLETED · clinicaltrials.gov

NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT00780819 — Borderzone Sampling

Status: COMPLETED · clinicaltrials.gov

NCT05765812 — A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT01100177 — Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Status: COMPLETED · clinicaltrials.gov

NCT02431572 — A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Status: COMPLETED · clinicaltrials.gov

NCT02678975 — Disulfiram in Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT01833273 — Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA

Status: COMPLETED · clinicaltrials.gov

NCT01699269 — Histopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor Imaging

Status: COMPLETED · clinicaltrials.gov

NCT04547855 — Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

Status: UNKNOWN · clinicaltrials.gov

NCT07493447 — Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT05708352 — A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Status: RECRUITING · clinicaltrials.gov

NCT06954636 — Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Status: RECRUITING · clinicaltrials.gov

NCT00436436 — O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Status: TERMINATED · clinicaltrials.gov

NCT07457307 — Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT07141732 — Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Status: RECRUITING · clinicaltrials.gov

NCT03633552 — Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

Status: UNKNOWN · clinicaltrials.gov

NCT04945148 — Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

Status: RECRUITING · clinicaltrials.gov

NCT01013285 — Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Status: COMPLETED · clinicaltrials.gov

NCT06710249 — Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

Status: RECRUITING · clinicaltrials.gov

NCT04656535 — AB154 Combined With AB122 for Recurrent Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT02129335 — Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner

Status: TERMINATED · clinicaltrials.gov

NCT02520635 — Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients

Status: UNKNOWN · clinicaltrials.gov

NCT06558214 — OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial

Status: RECRUITING · clinicaltrials.gov

NCT00402116 — Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Status: COMPLETED · clinicaltrials.gov

NCT04440358 — Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

Status: COMPLETED · clinicaltrials.gov

NCT01478178 — Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Status: COMPLETED · clinicaltrials.gov

NCT02631655 — POSitron Emission Imaging Using 18F-FDOPA in Neurooncology

Status: COMPLETED · clinicaltrials.gov

NCT07485049 — BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Status: RECRUITING · clinicaltrials.gov

NCT04143425 — Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT01989884 — An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT03922984 — Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT02664363 — EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Status: TERMINATED · clinicaltrials.gov

NCT03687034 — A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma

Status: UNKNOWN · clinicaltrials.gov

NCT01222221 — Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT03618667 — GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

Status: COMPLETED · clinicaltrials.gov

NCT04854044 — ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma

Status: WITHDRAWN · clinicaltrials.gov

NCT00974987 — Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT05460507 — Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Status: RECRUITING · clinicaltrials.gov

NCT05753007 — A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Status: TERMINATED · clinicaltrials.gov

NCT00010036 — Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT03405792 — Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT01009307 — Study of Blood and Cheek Cell Samples From Patients With Glioma

Status: COMPLETED · clinicaltrials.gov

NCT04218019 — Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation

Status: WITHDRAWN · clinicaltrials.gov

NCT05879367 — Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Status: RECRUITING · clinicaltrials.gov

NCT07521657 — Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT07052877 — The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT02283944 — TMS Electrochemotherapy for Glioblastoma Multiforme

Status: WITHDRAWN · clinicaltrials.gov

NCT02658981 — Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Status: COMPLETED · clinicaltrials.gov

NCT04590664 — Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT00430911 — Radiotherapy for Malignant Astrocytomas in the Elderly

Status: COMPLETED · clinicaltrials.gov

NCT04959500 — Newly Diagnosed Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT04222309 — Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Status: SUSPENDED · clinicaltrials.gov

NCT02253212 — Safety of BBB Opening With the SonoCloud

Status: COMPLETED · clinicaltrials.gov

NCT04846257 — Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence

Status: COMPLETED · clinicaltrials.gov

NCT06556563 — EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT06177964 — Lerapolturev (PVSRIPO) in GBM

Status: RECRUITING · clinicaltrials.gov

NCT05241392 — Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT00609999 — Ph I Dasatinib + Erlotinib in Recurrent MG

Status: COMPLETED · clinicaltrials.gov

NCT00562419 — CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

Status: UNKNOWN · clinicaltrials.gov

NCT03897491 — PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT03367715 — Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT02152748 — Disease Progression and Treatment-induced Alterations in Glioblastoma

Status: UNKNOWN · clinicaltrials.gov

NCT03275558 — Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma

Status: WITHDRAWN · clinicaltrials.gov

NCT03466450 — Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT03048240 — INtraoperative photoDYnamic Therapy of GliOblastoma

Status: COMPLETED · clinicaltrials.gov

NCT04541225 — Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Status: TERMINATED · clinicaltrials.gov

NCT05267106 — Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

Status: TERMINATED · clinicaltrials.gov

NCT00823797 — Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Status: COMPLETED · clinicaltrials.gov

NCT02717962 — Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Status: COMPLETED · clinicaltrials.gov

NCT03630289 — Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT03370926 — FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy

Status: UNKNOWN · clinicaltrials.gov

NCT01782976 — Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Status: WITHDRAWN · clinicaltrials.gov

NCT00004024 — Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Status: COMPLETED · clinicaltrials.gov

NCT02649582 — Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT00895180 — Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT05879120 — Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma

Status: WITHDRAWN · clinicaltrials.gov

NCT00939991 — Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas

Status: COMPLETED · clinicaltrials.gov

NCT04474353 — Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT00643097 — Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT02617589 — An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Status: COMPLETED · clinicaltrials.gov

NCT03452579 — Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT03403803 — Prognosis and Therapeutic Biomarkers for Glioblastoma Patients

Status: TERMINATED · clinicaltrials.gov

NCT00884741 — Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT00720356 — Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Status: COMPLETED · clinicaltrials.gov

NCT04991870 — Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

Status: RECRUITING · clinicaltrials.gov

NCT05977322 — A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Status: TERMINATED · clinicaltrials.gov

NCT00305656 — AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT06973096 — CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

Status: RECRUITING · clinicaltrials.gov

NCT02444546 — Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Status: COMPLETED · clinicaltrials.gov

NCT06359379 — Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

Status: TERMINATED · clinicaltrials.gov

NCT00253669 — Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Status: COMPLETED · clinicaltrials.gov

NCT04047303 — CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT04908176 — A Drug-drug Interaction Study of Avapritinib and Midazolam

Status: COMPLETED · clinicaltrials.gov

NCT00095940 — Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors

Status: COMPLETED · clinicaltrials.gov

NCT05131815 — The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Status: COMPLETED · clinicaltrials.gov

NCT03152318 — A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT06146725 — The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Status: RECRUITING · clinicaltrials.gov

NCT00003185 — Biological Therapy in Treating Patients With Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT04536649 — Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.

Status: UNKNOWN · clinicaltrials.gov

NCT01870726 — Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT02575027 — Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT01342757 — Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT01430351 — Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy

Status: TERMINATED · clinicaltrials.gov

NCT05843253 — Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Status: RECRUITING · clinicaltrials.gov

NCT01109095 — CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM

Status: COMPLETED · clinicaltrials.gov

NCT04552886 — Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma

Status: COMPLETED · clinicaltrials.gov

NCT04135807 — Implantable Microdevice In Primary Brain Tumors

Status: RECRUITING · clinicaltrials.gov

NCT03970447 — A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT05131763 — NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Status: UNKNOWN · clinicaltrials.gov

NCT02974621 — Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT00916409 — Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Status: COMPLETED · clinicaltrials.gov

NCT06501911 — A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

Status: WITHDRAWN · clinicaltrials.gov

NCT05557292 — RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

Status: TERMINATED · clinicaltrials.gov

NCT07284628 — Vortioxetine for Newly Diagnosed Glioblastoma

Status: NOT_YET_RECRUITING · clinicaltrials.gov

NCT01873469 — Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

Status: COMPLETED · clinicaltrials.gov

NCT00723827 — Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

Status: COMPLETED · clinicaltrials.gov

NCT06499831 — 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas

Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov

NCT06850766 — The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma

Status: RECRUITING · clinicaltrials.gov

NCT06264388 — DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Status: RECRUITING · clinicaltrials.gov

NCT00499473 — Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Status: COMPLETED · clinicaltrials.gov